BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Song DS, Bae SH, Song MJ, Lee SW, Kim HY, Lee YJ, Oh JS, Chun HJ, Lee HG, Choi JY, Yoon SK. Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis. World J Gastroenterol 2013; 19(29): 4679-4688 [PMID: 23922465 DOI: 10.3748/wjg.v19.i29.4679]
URL: https://www.wjgnet.com/1948-5182/full/v19/i29/4679.htm
Number Citing Articles
1
Morihiko Ishizaki, Masaki Kaibori, Kosuke Matsui, Hiroki Ikeda, Katsunori Yoshida, Kazuichi Okazaki, Syuji Kariya, Noboru Tanigawa, Richi Nakatake, Hideyuki Matsushima, Tatsuma Sakaguchi, Masanori Kon. Phase I Study of Sorafenib in Combination with Intermittent Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular CarcinomaCancer Investigation 2017; 35(4): 271 doi: 10.1080/07357907.2017.1289382
2
T. Hamada, K. Yano, T. Wada, N. Imamura, M. Hiyoshi, K. Kondo, Atsushi Nanashima. Increased Survival Benefit of Adjuvant Intra-arterial Infusion Chemotherapy in HCC Patients with Portal Vein Infiltration after HepatectomyWorld Journal of Surgery 2020; 44(8): 2770 doi: 10.1007/s00268-020-05527-w
3
Ninggang Zheng, Xiaodong Wei, Dongzhi Zhang, Wenxiao Chai, Ming Che, Jiangye Wang, Binbin Du. Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombusMedicine 2016; 95(26): e3959 doi: 10.1097/MD.0000000000003959
4
Takahiro Yamasaki, Issei Saeki, Isao Sakaida. Efficacy of iron chelator deferoxamine for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma patients refractory to current treatmentsHepatology International 2014; 8(S2): 492 doi: 10.1007/s12072-013-9515-3
5
Xinyu Chen, Lin Lai, Jiazhou Ye, Lequn Li. Downstaging Therapies for Unresectable Hepatocellular Carcinoma Prior to Hepatic Resection: A Systematic Review and Meta-AnalysisFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.740762
6
Sang Yi Moon, Sang Young Han, Yang-Hyun Baek. Efficacy of Hepatic Arterial Infusion Chemotherapy and Radiofrequency Ablation against Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization and Vascular Variation: A Case StudyKosin Medical Journal 2021; 36(2): 161 doi: 10.7180/kmj.2021.36.2.161
7
Cisplatin/epirubicin/fluorouracilReactions Weekly 2021; 1853(1): 137 doi: 10.1007/s40278-021-95003-x
8
Hong-Tao Hu, Jun-Peng Luo, Guang-Shao Cao, Zhen Li, Ming Jiang, Chen-Yang Guo, Hang Yuan, Quan-Jun Yao, Xiang Geng, Jung-Hoon Park, Hong-Tao Cheng, Li Jiang, Jun-Li Ma, Yan Zhao, Hai-Liang Li. Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Transarterial Chemoembolization and Sorafenib vs.125Iodine ImplantationFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.806907
9
Siqi Zhao, Wubin Zheng, Chao Yu, Gaoxin Xu, Xinyi Zhang, Chao Pan, Yongheng Feng, Kunxing Yang, Jin Zhou, Yong Ma. The Role of Ferroptosis in the Treatment and Drug Resistance of Hepatocellular CarcinomaFrontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.845232
10
Su Ho Kim, Jung Suk Oh, Ho Jong Chun, Byung Gil Choi, Hae Giu Lee. Dual-Port versus Mono-Port Implantation for Intra-Arterial Chemoinfusion Therapy for Treatment of Hepatocellular Carcinoma in Patients with Anatomic Hepatic Artery VariationJournal of Vascular and Interventional Radiology 2019; 30(1): 23 doi: 10.1016/j.jvir.2018.06.006
11
Beom-Hui Lee, Dong-Shik Lee, Chan Woo Cho, Sung-Su Yun. Role and limitation of neoadjuvant hepatic arterial infusion chemotherapy in advanced hepatocelluar carcinoma patients with Child-Pugh class AWorld Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1685-6
12
Do Seon Song, Myeong Jun Song, Si Hyun Bae, Woo Jin Chung, Jae Young Jang, Young Seok Kim, Sae Hwan Lee, Jun Yong Park, Hyung Joon Yim, Sung Bum Cho, Soo Young Park, Jin Mo Yang. A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosisJournal of Gastroenterology 2015; 50(4): 445 doi: 10.1007/s00535-014-0978-3
13
Kuan-Ting Chen, Kun-Feng Tsai, Henry W. C. Leung, Agnes L. F. Chan, Shyh-Yau Wang, Huei-Lung Liang, Sheng-Yeh Tang, Chu-Kuang Chou, Hsin-Yu Chen, Shan-Ho Chan, Ming-Feng Li. Hepatic Arterial Infusion Chemotherapy Followed by Lipiodol Infusion for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Single-Center ExperienceMedicina 2021; 57(8): 779 doi: 10.3390/medicina57080779
14
Masahito Nakano, Takashi Niizeki, Hiroaki Nagamatsu, Masatoshi Tanaka, Ryoko Kuromatsu, Manabu Satani, Shusuke Okamura, Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Yu Noda, Hironori Koga, Takuji Torimura. Clinical effects and safety of intra‑arterial infusion therapy of cisplatin suspension in lipiodol combined with 5‑fluorouracil versus sorafenib, for advanced hepatocellular carcinoma with macroscopic vascular invasion without extra‑hepatic spread: A prospective cohort studyMolecular and Clinical Oncology 2017;  doi: 10.3892/mco.2017.1442
15
Rinpei Imamine, Toshiya Shibata, Ken Shinozuka, Kaori Togashi. Complications in hepatic arterial infusion chemotherapy: retrospective comparison of catheter tip placement in the right/left hepatic artery vs. the gastroduodenal arterySurgery Today 2017; 47(7): 851 doi: 10.1007/s00595-016-1465-7
16
Wei-Lun Tsai, Kwok-Hung Lai, Huei-Lung Liang, Ping-I Hsu, Hoi-Hung Chan, Wen-Chi Chen, Hsien-Chung Yu, Feng-Woei Tsay, Huay-Min Wang, Hung-Chih Tsai, Jin-Shiung Cheng, Erica Villa. Hepatic Arterial Infusion Chemotherapy for Patients with Huge Unresectable Hepatocellular CarcinomaPLoS ONE 2014; 9(5): e92784 doi: 10.1371/journal.pone.0092784
17
Zhu-Jian Deng, Le Li, Yu-Xian Teng, Yu-Qi Zhang, Yu-Xin Zhang, Hao-Tian Liu, Jian-Li Huang, Zhen-Xiu Liu, Liang Ma, Jian-Hong Zhong. Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and ControversyJournal of Clinical and Translational Hepatology 2022; 10(1): 147 doi: 10.14218/JCTH.2021.00179
18
Hee Chul Nam, Pil Soo Sung, Ho Jong Chun, Dong Goo Kim, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon. Liver Transplantation after Successful Downstaging with Hepatic Arterial Infusion Chemotherapy in a Patient with Hepatocellular Carcinoma with Portal Vein Tumor ThrombusJournal of Liver Cancer 2019; 19(1): 64 doi: 10.17998/jlc.19.1.64
19
Woo Kyun Bae, Byung Chan Lee, Hyeon-Jong Kim, Je-Jung Lee, Ik-Joo Chung, Sung Bum Cho, Yang Seok Koh. A Phase I Study of Locoregional High-Dose Autologous Natural Killer Cell Therapy With Hepatic Arterial Infusion Chemotherapy in Patients With Locally Advanced Hepatocellular CarcinomaFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.879452
20
Khadijah M. Alzaydi, Tamer S. Saleh. 2-Aryl hydrazonopropanal pharmacophores as potent cytotoxic agents against human hepatocellular carcinoma cell lineMedicinal Chemistry Research 2020; 29(2): 199 doi: 10.1007/s00044-019-02473-8
21
Young Eun Ahn, Sang Jun Suh, Hyung Joon Yim, Yeon Seok Seo, Eileen L. Yoon, Tae Hyung Kim, Young Sun Lee, Sun Young Yim, Hae Rim Kim, Seong Hee Kang, Young Kul Jung, Ji Hoon Kim, Jong Eun Yeon, Soon Ho Um, Kwan Soo Byun. Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor ThrombosisGut and Liver 2021; 15(2): 284 doi: 10.5009/gnl19367
22
Hong Tao Hu, Jun Peng Luo, Hai-Liang Li, Chen Yang Guo, Quan Jun Yao, Xiang Geng, Li Jiang. Transarterial chemoembolization combined with computed tomography-guided 125iodine implantation enhances survival in hepatocellular carcinoma patients with portal vein tumor thrombusOncotarget 2017; 8(17): 29258 doi: 10.18632/oncotarget.16491
23
Kichang Han, Jin Hyoung Kim, Gi-Young Ko, Dong Il Gwon, Kyu-Bo Sung. Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive reviewWorld Journal of Gastroenterology 2016; 22(1): 407-416 doi: 10.3748/wjg.v22.i1.407
24
Chae-June Lim, Ji-Yun Hong, Yang-Seok Ko, Min-Woo Chung, Chung-Hwan Jun, Sung-Kyu Choi, Sung-Bum Cho. High-dose versus Low-dose 5-Fluorouracil and Cisplatin Based Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular CarcinomaJournal of Liver Cancer 2019; 19(1): 38 doi: 10.17998/jlc.19.1.38